Paulson & Co. Votes in Support of Mylan's Proposed Merger with Perrigo
August 14 2015 - 1:30PM
PR Newswire (US)
NEW YORK, Aug. 14, 2015 /PRNewswire/ -- On behalf of funds
that it manages, Paulson & Co. today voted all of its 21.9
million Mylan (NASDAQ: MYL) shares in support of the proposed
merger with Perrigo (NYSE: PRGO).
John Paulson, President of
Paulson & Co., said "The combination of Mylan's unparalleled
generic capabilities with Perrigo's attractive OTC platform would
create a global pharmaceutical powerhouse. The combined
company will benefit from the growth in generics and OTC plus the
migration of generics to OTC for many years to come. Mylan
management has a successful track record of integrating
acquisitions. The transaction is expected to be accretive based on
cost synergies alone and likely meaningfully accretive when revenue
synergies are taken into account."
Paulson & Co., founded in 1994 is an investment management
firm specializing in event-driven strategies. Paulson has
approximately US$20 billion in assets
under management and has offices in New
York, London and
Hong Kong.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/paulson--co-votes-in-support-of-mylans-proposed-merger-with-perrigo-300128801.html
SOURCE Paulson & Co. Inc.
Copyright 2015 PR Newswire
Mylan NV (NASDAQ:MYL)
Historical Stock Chart
From Mar 2024 to Apr 2024
Mylan NV (NASDAQ:MYL)
Historical Stock Chart
From Apr 2023 to Apr 2024